Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

LY333531 treatment for symptomatic peripheral neuropathy in patients with diabetes

Trial Profile

LY333531 treatment for symptomatic peripheral neuropathy in patients with diabetes

Completed
Phase of Trial: Phase III

Latest Information Update: 28 Jul 2006

At a glance

  • Drugs Ruboxistaurin (Primary)
  • Indications Peripheral nervous system diseases
  • Focus Registrational; Therapeutic Use
  • Most Recent Events

    • 28 Jul 2006 Status change
    • 23 Oct 2005 New trial record.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top